Analysis of fungal contamination and disinfection of toothbrushes

The aim of this study is to determine the fungal species in the toothbrushes of residents of a neighborhood on the east side of Teresina - PI, and to assess the efficiency of a disinfection method based on 2% sodium hypochlorite. Fifty toothbrushes were divided into two groups: group A comprised 30 toothbrushes used by the residents and group B (control group) 20 new toothbrushes. Fungal evaluation was conducted in Sabouraud culture medium containing chloramphenicol and CHROMagar Candida. Later group A was divided into two subgroups (A1 and A2), which were submitted to disinfection by immersion in 2% sodium hypochlorite and once again screened for the presence of fungi. Seventeen fungal species were identified in group A before the disinfection. Fungal growth was not observed in subgroups A1 and A2, or group B after disinfection. All fungal species isolated from the toothbrushes were considered opportunistic and may cause health problems mainly in immunocompromised patients. The species most frequently found were: Candida albicans, Aspergillus niger, Penicillium citrinum, Geotrichum candidum, Aspergillus fumigatus and Cladosporium oxysporum. Fungal growth did not occur after toothbrush disinfection with 2% sodium hypochlorite, suggesting this is an efficient, low-cost method that can therefore be used by low income populations.     

The family and the mental disturbance carrier: dynamics and their family relationship

This exploratory study was performed from September to November 2008, with six families of patients with mental disorders from a patients and family association in Curitiba. Objectives: to learn about the role of the family of patients with mental disorders, and to identify the family's perception of mental health - mental disorder, the patient with mental disorder and the mental health treatment. The data was obtained through Group Discussions and organized into thematic categories. It was found that the role of the family is to care, encourage, be there; mental health is the ability to establish relationships, perform activities without suffering; mental disorder is the opposite, in face of which the families feel helpless; hospitalization is seen as suffering, and the highlight is on the importance of the drug treatment. It is necessary to discuss on these issues with the families and prepare health professionals to meet these new health needs.     

An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia

OBJECTIVE: We conducted this 6-week open-label trial to examine the effects of adjunctive aripiprazole in clozapine-treated subjects on weight, lipid and glucose metabolism, as well as positive and negative symptoms of schizophrenia. METHOD: Ten clozapine-treated subjects received aripiprazole augmentation; eight completed the 6-week trial and two ended at week 4. Eighty percent were male, the mean age was 38.7 +/- 8.9 years and the mean clozapine dose was 455 +/- 83 mg daily. RESULTS: There was a significant decrease in weight (P = 0.003), body mass index (P = 0.004), fasting total serum cholesterol (P = 0.002) and total triglycerides (P = 0.04) comparing baseline to study endpoint. There was no significant change in total Positive and Negative Syndrome Scale scores. CONCLUSION: This combination may be useful for clozapine-associated medical morbidity and must be studied in placebo-controlled double-blind randomized trials to determine efficacy and safety.     

Glucose metabolism in patients with schizophrenia treated with olanzapine or quetiapine: a frequently sampled intravenous glucose tolerance test and minimal model analysis

OBJECTIVE: Clozapine and olanzapine treatment has been associated with insulin resistance in non-obese schizophrenia patients. Much less is known regarding other agents such as quetiapine. The objective of this study was to compare matched olanzapine- and quetiapine-treated schizophrenia patients and normal controls on measures of glucose metabolism. METHOD: A cross-sectional comparison of quetiapine-treated and olanzapine-treated non-obese (body mass index < 30.0 kg/m2) schizophrenia subjects (DSM-IV) with matched normal controls using a frequently sampled intravenous glucose tolerance test and nutritional assessment was conducted from April 2002 to October 2004. Data from 24 subjects were included in the analysis (7 quetiapine, 8 olanzapine, 9 normal controls). RESULTS: There was a significant difference among groups for fasting baseline plasma glucose concentrations (p = .02), with olanzapine greater than normal controls (p = .01). The insulin sensitivity index (SI) differed significantly among groups (p = .039); olanzapine subjects exhibited significant insulin resistance compared to normal controls (p = .01), but there was no significant difference for quetiapine versus olanzapine (p = .1) or quetiapine versus normal controls (p = .40). SI inversely correlated with quetiapine dose (p = .0001) and waist circumference (p = .03) in quetiapine-treated subjects. Insulin resistance calculated by the homeostasis model assessment of insulin resistance (HOMA-IR) also differed significantly among groups (p = .03). The olanzapine group had a higher HOMA-IR level than normal controls (p = .01). There was a significant difference in glucose effectiveness (SG) among the groups (p = .049). SG was lower in the olanzapine group than in the quetiapine group (p = .03) and in the olanzapine group compared to normal controls (p = .049). CONCLUSIONS: Our findings are consistent with our previous report that nonobese olanzapine-treated subjects showed insulin resistance, measured by both HOMA-IR and SI, and reduction in SG. Studies that include larger samples, unmedicated patients, and varying durations of antipsychotic exposure are necessary to confirm these results.     

Development of 13 microsatellite loci in the spotted snow skink Niveoscincus ocellatus (Squamata: Scincidae)

Thirteen polymorphic tri- and tetra-nucleotide microsatellites are reported for the spotted snow skink (Niveoscincus ocellatus) from Tasmania. Variation was assessed among 40 individuals collected from a single locality. Most loci had 12–19 alleles, although one had more than 20 alleles, while observed heterozygosities ranged between 0.25 and 0.93. Eleven loci were also polymorphic in the congeneric species N. metallicus (N = 16 collected from a single locality).     

Ruta graveolens L. toxicity in Vampirolepis nana infected mice

Objective:

To determine possible toxic effects of Ruta graveolens hydroalcoholic extract in gastrointestinal parasitic infection.

Materials and Methods:

A total of 100 g plant leaves and seeds were powdered and extracted with 1500 mL alcohol/water and administered by gavage to Swiss albino mice infected with Vampirolepis nana. Anti-parasitic evaluation and toxicity assays were carried out in six groups of ten animals each. Treatments were scheduled with both the leaves and the seeds’ extracts at doses of 2.5, 5, and 10 mg per gram body weight. Toxicity was comparatively analyzed to a vehicle control group (n = 10) and to a Praziquantel^® treated. On the fifth day, all the individuals were killed by euthanasia and parasite scores were correlated, giving rise to a relative percentage of elimination to each treatment. Toxicity was achieved by hematology and by clinical chemistry determinations.

Results:

The use of the R. graveolens hydroalcoholic extract to treat V. nana infected mice resulted in a mild-to-moderate hepatoxicity associated to a poor anti-parasitic effect. The major proglottids elimination (E%) was achieved at the lowest crude extract concentration with a mild anti-parasitic efficacy from the highest dose; that did not cause a significant elimination of parasites. A decrease of circulating polymorphonuclear-neutrophils associated with a normochromic-normocytic anemia was detected as the extract dose was augmented. The blood aspartate-aminotransferase and alanine-aminotransferase tended be slightly augmented with 100 mg R. graveolens extract.

Conclusion:

R. graveolens is an unsafe natural anti-parasitic medicine as its active constituents may be poorly extracted by the popular crude herb infusion. Although it presented a mild anti-parasitic effect in mice, symptoms of natural-products-induced-liver-disease confirmed that its self-medication should be avoided.     

Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects

We report Down syndrome (DS)-associated congenital gastrointestinal (GI) defects identified during a 15 year, population-based study of the etiology and phenotypic consequences of trisomy 21. Between 1989 and 2004, six sites collected DNA, clinical and epidemiological information on live-born infants with standard trisomy 21 and their parents. We used chi-squared test and logistic regression to explore relationships between congenital GI defects and infant sex, race, maternal age, origin of the extra chromosome 21, and presence of a congenital heart defect. Congenital GI defects were present in 6.7% of 1892 eligible infants in this large, ethnically diverse, population-based study of DS. Defects included esophageal atresia/tracheoesophageal fistula (0.4%), pyloric stenosis (0.3%), duodenal stenosis/atresia (3.9%), Hirschsprung disease (0.8%), and anal stenosis/atresia (1.0%). We found no statistically significant associations between these defects and the factors examined. Although not significant, esophageal atresia was observed more often in infants of younger mothers and Hispanics, Hirschsprung disease was more frequent in males and in infants of younger mothers and blacks, and anal stenosis/atresia was found more often among females and Asians.